Table 2.
Mean (SD) number of A1C1 follow-up tests by baseline A1C severity and glycemic control among United States veterans with a new type-2 diabetes diagnosis in 2008–2018.
| |
Baseline A1C1 severity |
||
|---|---|---|---|
| < 7.0 % M (SD) |
7.0 to 8.9 % M (SD) |
≥ 9.0 % M (SD) |
|
| Proportion of A1C 1 | |||
| Follow-up tests in-range | |||
| Less than 0.25 | 14.1 (9.3) | 14.3 (9.3) | 15.0 (9.7) |
| 0.25 to 0.49 | 13.6 (8.5) | 13.7 (8.4) | 14.8 (8.8) |
| 0.50 to 0.74 | 13.1 (7.4) | 13.3 (7.4) | 13.9 (7.7) |
| 0.75 to 1.00 | 9.6 (6.1) | 10.3 (6.6) | 11.4 (6.8) |
1
A1C = glycated hemoglobin, an indicator of glycemic control.